A5021322779- CAR-T cell therapy research
- Monoclonal and Polyclonal Antibodies Research
- Biosimilars and Bioanalytical Methods
- Gynecological conditions and treatments
- Nanowire Synthesis and Applications
- Uterine Myomas and Treatments
- Endometrial and Cervical Cancer Treatments
- Appendicitis Diagnosis and Management
- Ovarian cancer diagnosis and treatment
- Maternal and fetal healthcare
- Cancer Mechanisms and Therapy
- Advancements in Semiconductor Devices and Circuit Design
- Pelvic floor disorders treatments
- Gastrointestinal disorders and treatments
- Cancer, Stress, Anesthesia, and Immune Response
- Intraperitoneal and Appendiceal Malignancies
- Diversity and Career in Medicine
- Electrolyte and hormonal disorders
- Pelvic and Acetabular Injuries
- Biomedical and Chemical Research
- Reproductive tract infections research
- Endometriosis Research and Treatment
- Cancer Immunotherapy and Biomarkers
- Anesthesia and Neurotoxicity Research
- Maternal and Perinatal Health Interventions
Tel Aviv University
2016-2025
Tel Aviv Sourasky Medical Center
2016-2022
Sheba Medical Center
2022
Academic College of Tel Aviv-Yafo
2019
Background: Hyponatremia during labor and delivery may result in severe maternal neonatal sequelae. Our aim was to describe the direct effect of hyponatremia on pregnancy outcome.Methods: A case series parturients diagnosed with their neonates. Clinical presentation, laboratory workup, outcomes are presented.Results: Four corresponding six neonates were hyponatremia. Of these, two cases caused by water intoxication preeclampsia induced. While identified due or symptoms, routine testing. In...
Abstract The pioneering design of chimeric antigen receptor (CAR) T-cell therapy demonstrated the potential reprogramming immune system. Nonetheless, exhaustion, toxicity, and suppressive microenvironments limit their efficacy in solid tumors. We previously characterized a subset tumor-infiltrating CD4+ T cells expressing FcγRI receptor. Herein, we detail engineering receptor, based on structure, allowing to target tumor using antibody intermediates. These showed effective specific...
<p>Supplementary tables and figures</p>
<div>Abstract<p>The pioneering design of chimeric antigen receptor (CAR) T-cell therapy demonstrated the potential reprogramming immune system. Nonetheless, exhaustion, toxicity, and suppressive microenvironments limit their efficacy in solid tumors. We previously characterized a subset tumor-infiltrating CD4<sup>+</sup> T cells expressing FcγRI receptor. Herein, we detail engineering receptor, based on structure, allowing to target tumor using antibody intermediates....
<div>Abstract<p>The pioneering design of chimeric antigen receptor (CAR) T-cell therapy demonstrated the potential reprogramming immune system. Nonetheless, exhaustion, toxicity, and suppressive microenvironments limit their efficacy in solid tumors. We previously characterized a subset tumor-infiltrating CD4<sup>+</sup> T cells expressing FcγRI receptor. Herein, we detail engineering receptor, based on structure, allowing to target tumor using antibody intermediates....
<p>Supplementary tables and figures</p>
<p>Supplementary tables and figures</p>
<div>Abstract<p>The pioneering design of chimeric antigen receptor (CAR) T-cell therapy demonstrated the potential reprogramming immune system. Nonetheless, exhaustion, toxicity, and suppressive microenvironments limit their efficacy in solid tumors. We previously characterized a subset tumor-infiltrating CD4<sup>+</sup> T cells expressing FcγRI receptor. Herein, we detail engineering receptor, based on structure, allowing to target tumor using antibody intermediates....
<p>Supplementary tables and figures</p>
(Abstracted from J Minim Invasive Gynecol 2019;26:535–543) Tubo-ovarian abscess (TOA) presents as an infectious mass of the adnexa and is a late complication pelvic inflammatory disease (PID) in up to 30% cases. TOA associated with significant patient morbidities, including pain, sepsis, recurrent hospitalizations may lead long-term complications such chronic adhesions, infertility, ectopic pregnancies.
Objective: To characterize office and operating room hysteroscopy in women 70 years of age or older. Design: This was a retrospective chart analysis. Setting: A single tertiary-care medical center. Population: All aged older who underwent procedure between March 2011 August 2018. Methods: hysteroscopic interventions performed during the study period were reviewed. patients had at least one gynecological examination that included an ultrasound prior to hysteroscopy. Main outcome measures:...
Abstract Background: Women 70 years of age or older with suspected endometrial pathologies would especially benefit from office hysteroscopy due to the risks anesthesia and high rates clinically significant findings in this group. However, performing those patients can be technically challenging, patient cooperation, which is essential for success procedure, may compromised The objective present study was characterize clinical procedural features operating-room women older. Methods: This a...
Abstract Background: Women 70 years of age or older with suspected endometrial pathologies would especially benefit from office hysteroscopy due to the risks anesthesia and high rates clinically significant findings in this group. However, performing those patients can be technically challenging, patient cooperation, which is essential for success procedure, may compromised The objective present study was characterize clinical procedural features operating-room women older. Methods: This a...